Daidzein-rich supplement shows menopause potential

A dietary supplement rich in the soy isoflavone daidzein can reduce the incidence of hot flushes by 52 per cent, suggests new research from Harvard Medical School. Moreover, no negative side effects were reported by the researchers, following the 12-week trial with 147 post-menopausal women and published in Menopause, the journal of the North American Menopause Society. The new study, led by George Blackburn, assigned the subjects to receive daily supplements of the daidzein-rich isoflavone-aglycone (DRI) supplement at a dose of either 40 or 60 milligrams, or placebo for 12 weeks. At the end of the study, the researchers report that the number of hot flushes in the group receiving the lower dose was reduced by 52 per cent, while the women receiving the higher dose experienced a 51 per cent reduction in the number of hot flushes. The placebo group reported a 39 per cent reduction in hot flush frequency.
Category: Productos

Source: NutraIngredients